• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Gazim X
    / CTS


    Active Ingredient
    Simethicone 125 mg

    Status in Israel
    OTC

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Tablets

    30 X 125 mg

    not in the basket chart 11938

    Related information


    Dosage

    Adults and children over 12 years old: 1-2 tablets as required after meals or at bedtime.
    Do not take more than 4 tablets in 24 hours.
    Do not exceed the stated dose.
    Children under 12 years of age: Not recommended.


    Indications

    Alleviation of flatulence and hyperacidity.


    Contra-Indications

    Hypersensitivity.


    Special Precautions

    This medicinal product contains Dextrates (purified mixture of saccharides). Patients with rare glucose-galactose malabsorption should not take this medicine.


    Side Effects

    Minor adverse effects: nausea and constipation.
    Rarely, hypersensitivity reactions such as rash, pruritis, facial oedema, tongue oedema and respiratory difficulty have been reported.


    Drug interactions

    Levothyroxine may bind to simeticone. Absorption of levothyroxine may be impaired if Gazim X are given concurrently to infants treated for thyroid disorders.


    Pregnancy and Lactation

    As simeticone is not absorbed, it is not anticipated that Gazim X will have any adverse effects on pregnancy and lactation. However, as with all drugs, caution should be exercised in these conditions.


    Overdose

    No cases of overdose have been reported. Theoretically, constipation may occur. Treat with fluids and keep under observation.


    Manufacturer
    CTS Chemical Industries Ltd
    CLOSE